CTRI/2011/08/001981
Completed
Phase 4
To compare the efficacy and tolerability of methylphenidate and atomoxetine in children with attention deficit hyperactivity disorder.
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Department of Psychiatry
- Enrollment
- 69
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients from 6 to 15 years of age with the diagnosis of Attention Deficit Hyperactivity Disorder according to Diagnostic and Statistical Manual of Mental Disorders\-IV\-Text Revision.
- •Patients with moderate to severe illness as assessed by Clinical Global Impressions Severity Scale.
- •Patients whose parents are willing to provide informed consent for participating in the study.
Exclusion Criteria
- •Patients with history of non\-response or adverse drug reactions to methylphenidate or atomoxetine in the past.
- •Patients who have taken any medication for ADHD in past one month.
- •Patients with history of heart disease, seizures, bipolar affective disorder, psychotic illness, pervasive developmental disorder, substance abuse, anxiety, mental retardation or tic disorder.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 3
Effect of methylene blue on treatment of COVID-19 patientsIRCT20191228045924N1Mashhad University of Medical Sciences80
Recruiting
Phase 1
This is a phase 2, randomized, double blind, multicenter study evaluating the efficacy and safety of the combination of methotrexate plus UVB TL01 in vitiligo.Vitiligo with new lesions or extension of old lesions during the last 6 monthsTherapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]CTIS2024-512766-34-00Centre Hospitalier Universitaire De Bordeaux48
Active, not recruiting
Phase 1
Etude d’efficacité et d’acceptabilité du méthylphénidate dans les troubles de la marche de la maladie de Parkinson : Etude multicentrique en double aveugle versus placebo. - PARGKAIT IIEUCTR2008-005801-20-FRCentre Hospitalier Régional et Universitaire de Lille69
Not yet recruiting
Phase 1
DMD Trial with Exon Skipping TechniqueCTRI/2022/03/041060Muscular Dystrophy Patients Welfare Society
Completed
Phase 2
Comparison between the effectiveness of methadone & Acceptance & Commitment group combination therapy & methadone therapy in the prevention rate of relapse in people with opium abuse.Mental & behavioural disorders due to use of opioids.Mental and behavioural disorders due to use of opioidsIRCT2016062328603N1Vice chancellor for research Zanjan University of Medical Sciences30